Listing timing unconfirmed
Last verified 21 Oct 2026The previously expected date of 16 Oct 2026 has passed. Trading has not been confirmed.
- IPO price
- $18.00Per share · USD
- Previously expected
- 16 Oct 2026Listing timing unconfirmed
Company overview
CITY THERAPEUTICS websiteCITY THERAPEUTICS is a clinical-stage biotechnology company. It is developing RNA interference therapeutics designed to silence the expression of disease-relevant proteins.
- Company country
- United States
Offering details
USD · Base offering, before overallotment
- Exchange
- Nasdaq Global Market
- Ticker
- CTY
- Shares offered
- 11,111,111
- Shares after offering
- 51,721,168
- New shares
- 11,111,111
- Existing shares sold
- 0
IPO timeline
- Registration filed
- Proposed terms publishedCITY THERAPEUTICS sets an IPO price range
- Proposed terms publishedCITY THERAPEUTICS sets an IPO price range
- Proposed terms publishedCITY THERAPEUTICS sets an IPO price range
- Final offer price announced
- Final offer price announced
- Proposed terms published
- Previously expected first trading day · Estimated date
Filings and documents
- Pricing announcementChecked 21 Oct 2026 (undated source)View document
- View document
- Updated offering termsChecked 9 Oct 2026 (undated source)View document
- Updated offering termsChecked 9 Oct 2026 (undated source)View document
- View document
- View document
- View document
- View document
Advisers
- Underwriter
- Goldman Sachs & Co. LLC